HC Wainwright Adjusts Price Target on Cytosorbents to $5.50 From $9, Maintains Buy Rating
HC Wainwright Adjusts Price Target on Cytosorbents to $5.50 From $9, Maintains Buy Rating
HC Wainwright將細胞吸附劑的目標價格從9美元調整爲5.50美元,維持買入評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊